SelfDecode is revolutionizing the healthcare industry with its AI software that offers personalized health recommendations. The platform utilizes a combination of DNA, labs, and environmental factors to provide integrated health solutions. Notably, the company is the world's sole provider of ancestry-adjusted Polygenic Risk Scoring for consumers.
Founded in 2016, SelfDecode operates within the Health Care and Sports industries. The company's R&D division, OmicsEdge, aims to make precision health accessible by enabling organizations to develop tailored healthcare products utilizing their bioinformatics infrastructure. Their key offering includes ancestry-adjusted Polygenic Risk Scoring, which they license to other entities.
Despite the absence of specific headquarters or disclosed recent investments and investors, SelfDecode's pioneering approach to personalized health solutions positions it as a notable player in the rapidly developing intersection of healthcare and AI.
